↓ Skip to main content

PLOS

BPR1K653, a Novel Aurora Kinase Inhibitor, Exhibits Potent Anti-Proliferative Activity in MDR1 (P-gp170)-Mediated Multidrug-Resistant Cancer Cells

Overview of attention for article published in PLOS ONE, August 2011
Altmetric Badge

Mentioned by

twitter
1 X user
patent
2 patents

Readers on

mendeley
17 Mendeley
Title
BPR1K653, a Novel Aurora Kinase Inhibitor, Exhibits Potent Anti-Proliferative Activity in MDR1 (P-gp170)-Mediated Multidrug-Resistant Cancer Cells
Published in
PLOS ONE, August 2011
DOI 10.1371/journal.pone.0023485
Pubmed ID
Authors

Chun Hei Antonio Cheung, Wen-Hsing Lin, John Tsu-An Hsu, Tzyh-Chyuan Hour, Teng-Kuang Yeh, Shengkai Ko, Tzu-Wen Lien, Mohane Selvaraj Coumar, Jin-Fen Liu, Wen-Yang Lai, Hui-Yi Shiao, Tian-Ren Lee, Hsing-Pang Hsieh, Jang-Yang Chang

Abstract

Over-expression of Aurora kinases promotes the tumorigenesis of cells. The aim of this study was to determine the preclinical profile of a novel pan-Aurora kinase inhibitor, BPR1K653, as a candidate for anti-cancer therapy. Since expression of the drug efflux pump, MDR1, reduces the effectiveness of various chemotherapeutic compounds in human cancers, this study also aimed to determine whether the potency of BPR1K653 could be affected by the expression of MDR1 in cancer cells.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 17 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 17 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 6 35%
Student > Bachelor 2 12%
Student > Master 2 12%
Student > Ph. D. Student 2 12%
Lecturer 1 6%
Other 3 18%
Unknown 1 6%
Readers by discipline Count As %
Medicine and Dentistry 7 41%
Agricultural and Biological Sciences 3 18%
Immunology and Microbiology 1 6%
Biochemistry, Genetics and Molecular Biology 1 6%
Neuroscience 1 6%
Other 1 6%
Unknown 3 18%